Correlation Between Edgewise Therapeutics and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Stoke Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Stoke Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Stoke Therapeutics
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Edgewise and Stoke is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Stoke Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.79 times more return on investment than Stoke Therapeutics. However, Edgewise Therapeutics is 1.26 times less risky than Stoke Therapeutics. It trades about -0.2 of its potential returns per unit of risk. Stoke Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 3,080 in Edgewise Therapeutics on October 20, 2024 and sell it today you would lose (454.00) from holding Edgewise Therapeutics or give up 14.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Edgewise Therapeutics vs. Stoke Therapeutics
Performance |
Timeline |
Edgewise Therapeutics |
Stoke Therapeutics |
Edgewise Therapeutics and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewise Therapeutics and Stoke Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |